Multimodal and simultaneous assessments of brain and spinal fluid abnormalities in chronic fatigue syndrome and the effects of psychiatric comorbidity.

TitleMultimodal and simultaneous assessments of brain and spinal fluid abnormalities in chronic fatigue syndrome and the effects of psychiatric comorbidity.
Publication TypeJournal Article
Year of Publication2017
AuthorsNatelson BH, Mao X, Stegner AJ, Lange G, Vu D, Blate M, Kang G, Soto E, Kapusuz T, Shungu DC
JournalJ Neurol Sci
Volume375
Pagination411-416
Date Published2017 Apr 15
ISSN1878-5883
KeywordsAdult, Analysis of Variance, Brain, Cerebrovascular Circulation, Cohort Studies, Fatigue Syndrome, Chronic, Female, Glutathione, Humans, Lactic Acid, Magnetic Resonance Spectroscopy, Male, Mental Disorders, Middle Aged, Neuropsychological Tests, Psychiatric Status Rating Scales
Abstract

The purpose of this study was to investigate whether CFS patients without comorbid psychiatric diagnoses differ from CFS patients with comorbid psychiatric diagnoses and healthy control subjects in neuropsychological performance, the proportion with elevated spinal fluid protein or white cell counts, cerebral blood flow (CBF), brain ventricular lactate and cortical glutathione (GSH). The results of the study did not show any differences in any of the outcome measures between CFS patients with and without psychiatric comorbidity, thus indicating that psychiatric status may not be an exacerbating factor in CFS. Importantly, significant differences were found between the pooled samples of CFS compared to controls. These included lower GSH and CBF and higher ventricular lactate and rates of spinal fluid abnormalities in CFS patients compared to healthy controls. Thirteen of 26 patients had abnormal values on two or more of these 4 brain-related variables. These findings, which replicate the results of several of our prior studies, support the presence of a number of neurobiological and spinal fluid abnormalities in CFS. These results will lead to further investigation into objective biomarkers of the disorder to advance the understanding of CFS.

DOI10.1016/j.jns.2017.02.046
Alternate JournalJ Neurol Sci
PubMed ID28320179
PubMed Central IDPMC5393352
Grant ListR01 MH100005 / MH / NIMH NIH HHS / United States
R21 NS075653 / NS / NINDS NIH HHS / United States
S10 OD021782 / OD / NIH HHS / United States
UL1 TR002384 / TR / NCATS NIH HHS / United States
Related Institute: 
MRI Research Institute (MRIRI)

Weill Cornell Medicine
Department of Radiology
525 East 68th Street New York, NY 10065